Françoise Brun-Vézinet

Update of the Drug Resistance Mutations in HIV-1.

H. Gunthard, J. Schapiro, Victoria A. Johnson, 2008, Topics in HIV medicine : a publication of the International AIDS Society, USA.

Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA Panel.

S. Hammer, M. Hirsch, D. Richman, 2000, JAMA.

Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel.

H. Günthard, J. Schapiro, J. Mellors, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Gag Mutations Can Impact Virological Response to Dual-Boosted Protease Inhibitor Combinations in Antiretroviral-Naïve HIV-Infected Patients

R. Landman, G. Collin, A. Storto, 2010, Antimicrobial Agents and Chemotherapy.

Polymorphism of the Human Immunodeficiency Virus Type 2 (HIV-2) Protease Gene and Selection of Drug Resistance Mutations in HIV-2-Infected Patients Treated with Protease Inhibitors

F. Brun-Vézinet, F. Mammano, G. Peytavin, 2005, Journal of Clinical Microbiology.

Immunovirological and therapeutic follow-up of HIV-1/HIV-2-dually seropositive patients

C. Cohen, M. de Béthune, D. Berger, 2009, AIDS.

Human Immunodeficiency Virus Type 1 (HIV-1) Plasma Load Discrepancies between the Roche COBAS AMPLICOR HIV-1 MONITOR Version 1.5 and the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 Assays

F. Brun-Vézinet, D. Descamps, B. Roquebert, 2007, Journal of Clinical Microbiology.